Literature DB >> 12503081

Overexpression of nPKC theta is inhibitory for agrin-induced nicotinic acetylcholine receptor clustering in C2C12 myotubes.

Kathryn Miles1, Michael Wagner.   

Abstract

Protein kinase C (PKC) activity has been implicated in nicotinic acetylcholine receptor (nAChR) cluster disruption but the specific PKC isoforms involved have not been identified. We first tested whether phorbol esters, which activate PKCs, regulate agrin-induced nAChR clustering in C(2)C(12) cells. We found that extended phorbol ester treatment (6 hr) increased nAChR clustering by two-fold. This increase correlated in time with downregulation of PKCs, as indicated by the disappearance of cPKC alpha, suggesting that the presence of PKCs is inhibitory for maximal nAChR clustering. To address the question whether nPKC theta, a specific PKC isoform restricted in expression to skeletal muscle and localized to neuromuscular junctions, regulates agrin-induced nAChR cluster formation we overexpressed an nPKC theta -green fluorescent protein (GFP) fusion protein in C(2)C(12) myotubes. The number of nAChR clusters was significantly reduced in nPKC theta-GFP compared to GFP overexpressing myotubes at less-than-maximal clustering concentrations of agrin. These data indicate that nPKC theta activity inhibits nAChR cluster formation. To examine whether nPKC theta activation by phorbol esters regulates agrin-induced nAChR clustering, we treated overexpressing myotubes overnight with maximal agrin concentrations followed by phorbol esters for 1 hr. Phorbol ester treatment reduced preexisting nAChR cluster numbers in nPKC theta-GFP compared to GFP-overexpressing myotubes, suggesting that stimulating nPKC theta activity disrupts nAChR clusters in the presence of maximal clustering concentrations of agrin. Together these findings, that nPKC theta activity inhibits agrin-induced nAChR cluster formation and disrupts preexisting agrin-induced nAChR clusters, suggest that nPKC theta activity is inhibitory for agrin function. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12503081     DOI: 10.1002/jnr.10467

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  Protein kinase C isoforms at the neuromuscular junction: localization and specific roles in neurotransmission and development.

Authors:  Maria A Lanuza; Manel M Santafe; Neus Garcia; Núria Besalduch; Marta Tomàs; Teresa Obis; Mercedes Priego; Phillip G Nelson; Josep Tomàs
Journal:  J Anat       Date:  2013-09-15       Impact factor: 2.610

2.  Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems.

Authors:  Ingrid Furlan; Rosely Oliveira Godinho
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk.

Authors:  Peiying Yu; Weixing Han; Van Anthony M Villar; Hewang Li; Francis B Arnaldo; Gisela P Concepcion; Robin A Felder; Mark T Quinn; Pedro A Jose
Journal:  Free Radic Biol Med       Date:  2010-12-28       Impact factor: 7.376

4.  Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylation.

Authors:  Joseph S Marino; Terry D Hinds; Rachael A Potter; Eric Ondrus; Jeremy L Onion; Abigail Dowling; Thomas J McLoughlin; Edwin R Sanchez; Jennifer W Hill
Journal:  BMC Cell Biol       Date:  2013-09-21       Impact factor: 4.241

5.  Lack of Fgf18 causes abnormal clustering of motor nerve terminals at the neuromuscular junction with reduced acetylcholine receptor clusters.

Authors:  Kenyu Ito; Bisei Ohkawara; Hideki Yagi; Hiroaki Nakashima; Mikito Tsushima; Kyotaro Ota; Hiroyuki Konishi; Akio Masuda; Shiro Imagama; Hiroshi Kiyama; Naoki Ishiguro; Kinji Ohno
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

6.  PKC and PKA regulate AChR dynamics at the neuromuscular junction of living mice.

Authors:  Isabel Martinez-Pena y Valenzuela; Marcelo Pires-Oliveira; Mohammed Akaaboune
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

7.  Opposed Actions of PKA Isozymes (RI and RII) and PKC Isoforms (cPKCβI and nPKCε) in Neuromuscular Developmental Synapse Elimination.

Authors:  Neus Garcia; Cori Balañà; Maria A Lanuza; Marta Tomàs; Víctor Cilleros-Mañé; Laia Just-Borràs; Josep Tomàs
Journal:  Cells       Date:  2019-10-23       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.